本页面由Tiger Trade Technology Pte. Ltd.提供服务

PTC Therapeutics Inc.

66.32
-2.2450-3.27%
成交量:16.96万
成交额:1,128.01万
市值:54.89亿
市盈率:8.52
高:68.12
开:67.91
低:65.50
收:68.56
52周最高:87.50
52周最低:35.95
股本:8,277.47万
流通股本:7,297.94万
量比:0.36
换手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):7.78
每股收益(LYR):7.78
净资产收益率:-7740.12%
总资产收益率:23.26%
市净率:-26.74
市盈率(LYR):8.52

数据加载中...

2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities